학술논문
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
Document Type
journal article
Author
Bachelot, Thomas; Cottu, Paul; Chabaud, Sylvie; Dalenc, Florence; Allouache, Djelila; Delaloge, Suzette; Jacquin, Jean-Philippe; Grenier, Julien; Venat Bouvet, Laurence; Jegannathen, Apurna; Campone, Mario; Del Piano, Francesco; Debled, Marc; Hardy-Bessard, Anne-Claire; Giacchetti, Sylvie; Mouret-Reynier, Marie-Ange; Barthelemy, Philippe; Kaluzinski, Laure; Mailliez, Audrey; Legouffe, Eric
Source
Journal of Clinical Oncology; 11/10/2022, Vol. 40 Issue 32, p3699-3708, 10p
Subject
Language
ISSN
0732183X